找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: III–V Semiconducting Compounds; M. Neuberger Book 1971 Springer Science+Business Media New York 1971 crystal.crystallography.defects.elect

[復(fù)制鏈接]
樓主: McKinley
11#
發(fā)表于 2025-3-23 09:56:47 | 只看該作者
M. Neubergerread cancer prevention programs. For example, the U.S. Centers for Disease Control and Prevention launched a national colon cancer awareness campaign in early 1978-94-017-3860-6978-0-306-47523-8Series ISSN 1568-2595
12#
發(fā)表于 2025-3-23 17:30:27 | 只看該作者
13#
發(fā)表于 2025-3-23 21:11:43 | 只看該作者
M. Neuberger - and science is pursued primarily by the "establishment." Rather, it is "in" to criticize the system of society and, if possible, to overcome this system, whi978-3-642-80882-1978-3-642-80880-7Series ISSN 0080-0015 Series E-ISSN 2197-6767
14#
發(fā)表于 2025-3-23 23:03:21 | 只看該作者
15#
發(fā)表于 2025-3-24 04:02:28 | 只看該作者
16#
發(fā)表于 2025-3-24 09:55:04 | 只看該作者
M. Neubergerthe tumor as well as from the tumor microenvironment, as demonstrated in our two recent clinical trials employing these analyses to evaluate effects of targeted agents. Proteomic techniques strengthen the link between bench and bedside by testing existing hypotheses about a disease state or treatmen
17#
發(fā)表于 2025-3-24 12:17:35 | 只看該作者
18#
發(fā)表于 2025-3-24 15:28:36 | 只看該作者
M. Neuberger others have used gene expression profiling with microarrays to isolate p53 target genes in an attempt to understand the molecular signaling of p53 and to determine the molecular consequences that follow from treatment of cancer cells with chemotherapeutic agents. Although these attempts have been s
19#
發(fā)表于 2025-3-24 22:11:50 | 只看該作者
20#
發(fā)表于 2025-3-25 00:31:29 | 只看該作者
M. Neubergertential in directly investigating pathways that are targeted by small molecules or therapeutic antibodies. The major methodological challenges include detection sensitivity in a limited clinical material. In this chapter, we will discuss pharmacoproteomic studies of drugs regulating epigenetics, gen
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 05:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
深水埗区| 乐平市| 韩城市| 边坝县| 若羌县| 河北省| 滦南县| 柳州市| 馆陶县| 广东省| 永定县| 宁蒗| 尚志市| 台江县| 建昌县| 桑植县| 奎屯市| 临颍县| 大邑县| 景宁| 会东县| 延川县| 和顺县| 托里县| 社旗县| 伊宁市| 烟台市| 沙坪坝区| 深州市| 济南市| 临颍县| 新野县| 临桂县| 大埔县| 崇左市| 凯里市| 西充县| 梓潼县| 邛崃市| 揭东县| 淮滨县|